PRO-DEX, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRO-DEX, INC. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $7.00K.
- PRO-DEX, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $33.00K.
- PRO-DEX, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $12.00K.
- PRO-DEX, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $39.00K.
- PRO-DEX, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $6.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $33.00K 10-K · filed 2026-09-03 | |
| 2023-06-30 | $12.00K 10-K · filed 2024-09-05 | |
| 2021-06-30 | $39.00K 10-K · filed 2023-10-13 | |
| 2019-06-30 | $6.00K 10-K · filed 2020-09-10 | |
| 2018-12-31 | $7.00K 10-Q · filed 2019-02-07 | |
| 2017-06-30 | $7.00K 10-K · filed 2018-09-13 | |
| 2016-06-30 | $16.00K 10-K · filed 2017-09-14 | |
| 2014-06-30 | $6.00K 10-K · filed 2015-09-17 | |
| 2013-06-30 | -$66.00K 10-K · filed 2014-09-18 | |
| 2011-06-30 | $43.00K 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |